We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Revolutionary Surgery Closure Device Could Reduce Patient Visits to OR

By HospiMedica International staff writers
Posted on 20 Feb 2023
Print article
Image: A cutting edge technology could revolutionize open abdomen closure and segment (Photo courtesy of InventoRR MD)
Image: A cutting edge technology could revolutionize open abdomen closure and segment (Photo courtesy of InventoRR MD)

Almost one in five open abdomen procedures in the US are left intentionally open for further treatment and later closed. However, a huge 38% of these "fail to close", resulting in additional visits to the operating room (OR) for sequential closure. This creates the risks of infection, prolonged time on a ventilator, loss of domain, increased attendant time, increased OR time, and even mortality, thereby adding a costly burden to the healthcare system. Now, an innovative device offers a non-invasive method for closing an open abdominal incision without surgery at the patient’s bedside, thereby improving patient safety and experience, while freeing up OR staff for other procedures.

InventoRR MD’s (Toronto, ON, Canada) flagship device, the AbClo, helps to facilitate primary closure of open abdomens and prevents loss of domain allowing surgeons to achieve closure successfully and on their timelines preventing negative patient outcomes and saving institutions time and money. AbClo works like a corset, supporting and stabilizing the abdominal wall to prevent damage and restore the equilibrium of the muscles in the torso. It can be applied in the ICU where it is sequentially tightened at the bedside so that the edges of the abdominal wall can meet in the middle for reattachment. While prescribed by a physician, it can be applied and monitored by other authorized healthcare providers, such as nurses. AbClo is licensed by Health Canada and the FDA.

“AbClo was developed to improve patient outcomes and make the post-surgical process easier for medical teams,” said InventoRR MD CEO Chris Bass.

Related Links:
InventoRR MD

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Breast Imaging Workstation
SecurView

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.